S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer.

Date of Notice

11/12/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Ozlem Tureci

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more BioNTech Charts.

BioNTech (NASDAQ:BNTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more BioNTech Charts.

BioNTech SE News

Form 144 - Report of proposed sale of securities
Saturday 16 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 13 November 2024 (1 week ago) • Edgar (US Regulatory)

BioNTech to Acquire Biotheus to Boost Oncology Strategy
Wednesday 13 November 2024 (1 week ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Tuesday 12 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 November 2024 (3 weeks ago) • Edgar (US Regulatory)

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
Monday 4 November 2024 (3 weeks ago) • GlobeNewswire Inc.

BioNTech to Host Innovation Series R&D Day on November 14, 2024
Thursday 31 October 2024 (3 weeks ago) • GlobeNewswire Inc.

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
Monday 21 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 19 October 2024 (1 month ago) • Edgar (US Regulatory)

More BioNTech SE News Articles

S&P ASX 300 Metals and M...

Verizon Communications

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions